Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Vaxzevria and mRNA COVID-19 vaccines showed similar and favourable safety profiles in a population-based cohort study of over a million people
-
Vaxzevria showed no increased incidence of thrombosis with thrombocytopenia after second dose
-
AstraZeneca and Regeneron to research, develop and commercialise new small molecule medicines for obesity
-
Ultomiris recommended for approval in the EU by CHMP for children and adolescents with paroxysmal nocturnal haemoglobinuria
-
Vaxzevria is highly effective after one dose against severe disease or hospitalisation caused by Beta and Delta variants of concern
-
Acquisition of Alexion completed
-
Imfinzi approved in China for the treatment of extensive-stage small cell lung cancer
-
Status on FDA Advisory Committee vote on roxadustat in anaemia of chronic kidney disease
-
AstraZeneca receives final regulatory clearance for the proposed acquisition of Alexion from the UK’s Competition and Markets Authority
-
Tezepelumab regulatory submission accepted and granted FDA Priority Review in the US for the treatment of patients with asthma
Latest articles and press releases
All of our latest press releases and articles are available to explore
